Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

Hospital of the University of Pennsylvania, Philadelphia

Duke Clinical Research Institute, Durham

University of Florida, Gainesville

Orlando Immunology Center, Orlando

University of Iowa, Iowa City

University of Colorado Health Sciences Center, Aurora

Quest Clinical Research, San Francisco

Auckland Clinical Studies Limited, Grafton

Fundacion de Investigacion de Diego, Santurce